Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff
Elanco Animal Health Incorporated (NYSE:ELAN) reported fourth-quarter revenue of $1.02 billion, a decrease of 1% on a ...
Elanco price target lowered to $13 from $14 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Elanco (ELAN) to $13 from $14 and keeps an Equal Weight rating on the shares. Q4 EPS of 14c ...
Elanco Animal Health to Commercialize Vaccine for Dairy Cattle to Battle Bird Flu Outbreak
Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.
Pharmabiz23h
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...
Elanco price target lowered to $15 from $16 at Stifel
Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the ...
Elanco Animal Health 4Q Loss Narrows, Sales Decline
Elanco Animal Health narrowed its fourth-quarter loss despite lower sales, but its forecast for the current quarter and full year came in below Wall Street's estimates.
Elanco Animal Health (ELAN) to Release Earnings on Tuesday
Elanco Animal Health (NYSE:ELAN – Get Free Report) is anticipated to announce its earnings results before the market opens on ...
Argenta Global settles into Shawnee manufacturing site after fall acquisition
A global manufacturer acquired a Shawnee facility in the fall, the third time it and its 300 employees have changed hands ...
Elanco slips as forex headwinds weigh on outlook
Elanco Animal Health (NYSE:ELAN) traded lower in the premarket on Tuesday after the veterinary product maker, with its Q4 2024 results, set its full-year outlook below consensus, citing an unfavorable ...